Imperial Innovations Group Regulatory News (IVO)

10 Oct 2006 07:01

Imperial Innovations Group plc10 October 2006 Imperial Innovations Group plc ("Imperial Innovations") Investment in InforSense Imperial Innovations Group plc (AIM: IVO), the technology transfer andcommercialisation company, today announces that it has invested £1.6 million inInforSense Limited ("InforSense"), a leading provider of software to the lifesciences, financial services and other industries. The investment in InforSense,which is the largest single investment Imperial Innovations has made to date,was part of a £5.3 million funding round which was jointly led by Fleming Familyand Partners Private Equity ("FF&P"). InforSense will use the investment to continue expanding its global footprintand to accelerate new product developments and additional applicationinitiatives in both its current and new markets. InforSense was formed by Imperial Innovations and Professor Yike Guo in 1999,based on the research conducted by Professor Guo and his team in the Departmentof Computing at Imperial College London. Imperial Innovations has continued tosupport the company since formation by introducing experienced management andproviding access to industrial customers, as well as investing in the company. Susan Searle, CEO, Imperial Innovations, said, "InforSense has shown tremendous growth in the last twelve months, with arapidly growing customer base. We are delighted to be able to support them asthey continue that growth with our largest single investment to date." Professor Yike Guo, InforSense's Founder and CEO, said, "We are pleased to have completed this round of strategic fund-raising and aregrateful to FF&P, Imperial Innovations, Elaia Partners, Sitka Health Fund VCTPlc and all our other shareholders for their continued support. With thesefunds, we are well positioned to increase our growth rate and capitalise on thecurrent success of our business." David Donnelly, CEO FF&P Private Equity, said, "FF&P Private Equity is delighted to continue to support InforSense. Theinvestment is in line with FF&P's philosophy of backing companies and managementteams that are successfully delivering innovative technologies and products tothe market. The Company is well placed to enjoy success in the years ahead." -Ends- For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 M:Communications +44 (0)20 7153 1539Patrick d'Ancona / Eleanor Williamson InforSense Ltd. +1 857 919 9975Tracy Coffey Donahue, Corporate CommunicationsOfficer Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £26 million. The company's integrated approach encompassesthe identification of ideas, protection of intellectual property, developmentand licensing of technology and formation, incubation and investment in spin-outcompanies. . A wide range of technologies are commercialised within the areas ofhealthcare, energy, environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in58 spin-out companies and has completed 90 commercial agreements. ImperialInnovations also commercialises technologies originating from outside ImperialCollege through incubation contracts with the Carbon Trust and WRAP and hasrelationships with a number of multinational corporations. Imperial Innovations has invested in a range of spin-out companies including TheAcrobot Company Limited, Cardiak Limited, deltaDOT Limited, Future Waves PTELimited, HeliSwirl Technologies Limited, InforSense Limited, Lontra Limited,Midaz Lasers Limited, NanoBiodesign Limited, Nexeon Limited, NovaThera Limited,Photobiotics Limited, Thiakis Limited and Veryan Medical Limited. Imperial Innovations currently holds shares in three spin-out companies nowlisted on AIM; fuel cell company, Ceres Power plc, and ParOS plc, a provider ofenergy-saving advanced control solutions, as well as Nanoscience plc, adeveloper of low power integrated circuits and silicon chips, following itsacquisition of spin-out company Toumaz Technology Limited. Website: www.imperialinnovations.co.uk About InforSense InforSense Ltd., the leader in integrative analytics, enables organizations toorchestrate and optimize their business-critical decision-making processes.Leading pharmaceutical, biotechnology, consumer goods and financial servicescompanies, and research institutes are using the company's flagship product,InforSense KDE, to enhance productivity across life science R&D, healthcare, andbusiness analytics. Inforsense is privately held, with European headquarters in London, UK and NorthAmerican headquarters in Cambridge, Massachusetts. Website: www.inforsense.com InforSense, TextSense and the InforSense logo are registered trademarks ofInforSense Limited. All rights reserved. All other trademarks mentioned in thisdocument are the property of their respective owners. This information is provided by RNS The company news service from the London Stock Exchange